Azitra Inc(AZTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AZTR Azitra Inc

Trading 07-13 10:25:15 EDT

0.1334

-0.0086

-6.06%

High0.1420	Low0.1300	Vol1.15M
Open0.1408	D1 Closing0.1420	Amplitude8.45%
Mkt Cap2.16M	Tradable Cap1.62M	Total Shares16.19M
T/O156.25K	T/O Rate9.49%	Tradable Shares12.13M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AZTR","market":"US","secType":"STK","nameCN":"Azitra Inc","latestPrice":0.1334,"timestamp":1783952692067,"preClose":0.142,"halted":0,"volume":1150817,"delay":0,"changeRate":-0.06056338028169012,"floatShares":12126500,"shares":16192438,"eps":-2.3107,"marketStatus":"Trading","change":-0.0086,"latestTime":"07-13 10:25:15 EDT","open":0.1408,"high":0.142,"low":0.13,"amount":156251.90197891998,"amplitude":0.084507,"askPrice":0.1355,"askSize":1200,"bidPrice":0.1301,"bidSize":1300,"shortable":3,"etf":0,"ttmEps":-2.3107,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1783972800000},"marketStatusCode":2,"adr":0,"listingDate":1684382400000,"exchange":"AMEX","adjPreClose":0.142,"preHourTrading":{"tag":"盘前","latestPrice":0.1407,"preClose":0.142,"latestTime":"09:23 EDT","volume":161394,"amount":23075.74936956,"timestamp":1783948994664,"change":-0.0013,"changeRate":-0.009155,"amplitude":0.084507},"postHourTrading":{"tag":"盘后","latestPrice":0.143,"preClose":0.142,"latestTime":"19:49 EDT","volume":13975,"amount":1997.818516,"timestamp":1783727399989,"change":0.001,"changeRate":0.007042,"amplitude":0.011972},"volumeRatio":6.110896},"requestUrl":"/m/hq/s/AZTR","defaultTab":"news","newsList":[{"id":"2644063590","title":"Why Did Azitra (AZTR) Stock Jump Over 25% After Hours?","url":"https://stock-news.laohu8.com/highlight/detail?id=2644063590","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644063590?lang=en_us&edition=fundamental","pubTime":"2026-06-19 15:06","pubTimestamp":1781852760,"startTime":"0","endTime":"0","summary":"Azitra shares jumped 25.45% after-hours following volatile trading session, financing updates and upcoming biotech presentation plans.","market":"sh","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/06/19/Trading-Investment-Charts--Investment-Fi.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/06/19/Trading-Investment-Charts--Investment-Fi.jpg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/26/06/60000312/why-did-azitra-aztr-stock-jump-over-25-after-hours","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/06/60000312/why-did-azitra-aztr-stock-jump-over-25-after-hours","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4139","AZTR","BK4150","RSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745987","title":"Azitra says shareholder letter is available","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745987","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644745987?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:02","pubTimestamp":1781697763,"startTime":"0","endTime":"0","summary":"Azitra announced the availability of a shareholder letter from CEO Francisco Salva outlining a strategic reorientation toward nearer-term milestones.Letter cites March financing of $10.5 million, with up to an additional $21 million tied to warrant exercises.Plans ATR-COSF recombinant filaggrin cosmetic ingredient program; targets fine lines and wrinkles; clinical study completion expected late 2026.Expands into recombinant proteins using in-licensed FHCC technologies; initial focus on TEV protease, T7 RNA polymerase; partnership or commercialization targeted within 36 months.ATR-04 trial for EGFR inhibitor-associated rash continues enrollment; ATR-12 Netherton syndrome enrollment paused to conserve capital.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL4YrBk4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644451617","title":"Azitra - to Pause Further Enrollment in Atr-12 Trial to Redirect Funds to Atr-Cosf","url":"https://stock-news.laohu8.com/highlight/detail?id=2644451617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644451617?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA57VSKH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644274552","title":"Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond","url":"https://stock-news.laohu8.com/highlight/detail?id=2644274552","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644274552?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA57VSKH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644487717","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2644487717","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644487717?lang=en_us&edition=fundamental","pubTime":"2026-06-17 19:08","pubTimestamp":1781694484,"startTime":"0","endTime":"0","summary":"Eshallgo  shares were up 296% in Wednesday premarket activity, adding to gains from the previous session.Azitra  shares were up 93% after the company said it will present updates on its pipeline, including a protein and peptide program for the cosmetic and cosmeceutical markets, at an upcoming conference.J-Star  stock was up 86% after a 37% decline in the previous session.Lunai Bioworks  stock was up 79%, continuing from Tuesday's 9% gain.Tianci International  shares were up 43%, recovering from the previous session's 70% decline","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CIIT","YMAT","BK4139","BK4143","LNAI","BK4190","BK4021","EHGO","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644793336","title":"Azitra COO Whitfill presents at BIO International Convention","url":"https://stock-news.laohu8.com/highlight/detail?id=2644793336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644793336?lang=en_us&edition=fundamental","pubTime":"2026-06-17 05:29","pubTimestamp":1781645368,"startTime":"0","endTime":"0","summary":"Azitra will present at the BIO International Convention in San Diego on June 23, 2026 at 4:45 PM PT.Cofounder and COO Travis Whitfill will outline pipeline progress, including a protein and peptide program leveraging filaggrin technology for cosmetics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL3KGNtl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643742754","title":"Azitra shareholders back increase in authorized common shares to 750 million at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2643742754","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643742754?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:04","pubTimestamp":1781611470,"startTime":"0","endTime":"0","summary":"Azitra held its annual shareholder meeting on June 15, 2026.Shareholders adopted an amendment increasing authorized common shares to 750,000,000 from 200,000,000; the charter amendment was filed June 15, 2026.Shareholders also adopted a charter amendment authorizing the board to implement one or more reverse stock splits; execution remains at the board’s discretion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL3ynTct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638636670","title":"BRIEF-Azitra Announces Intention To Adjourn Annual Meeting And Reconvene Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638636670","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638636670?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:32","pubTimestamp":1779913978,"startTime":"0","endTime":"0","summary":"BRIEF-Azitra Announces Intention To Adjourn Annual Meeting And Reconvene Annual MeetingMay 27 (Reuters) - Azitra Inc AZTR.A:AZITRA ANNOUNCES INTENTION TO ADJOURN ANNUAL MEETING AND RECONVENE ANNUAL ME","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN42415W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638763665","title":"Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638763665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638763665?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:30","pubTimestamp":1779913837,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN42415W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352014","title":"Azitra files to sell 255.7M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352014","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352014?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397249,"startTime":"0","endTime":"0","summary":"16:58 EDT Azitra (AZTR) files to sell 255.7M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, mark...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/azitra-files-to-sell-255-7m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/azitra-files-to-sell-255-7m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZTR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635478763","title":"Anitra Q1 EPS $(0.25) Misses $(0.12) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635478763","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635478763?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:54","pubTimestamp":1778676888,"startTime":"0","endTime":"0","summary":"Anitra (AMEX:AZTR) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 83.87 percent increase over losses of $(1.55) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52520779/anitra-q1-eps-0-25-misses-0-12-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635782515","title":"Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635782515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635782515?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:30","pubTimestamp":1778675404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nTUA1CFPJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635788300","title":"Azitra Q1 FY26 net loss widens to $3.9 million; G&A expenses rise to $2.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635788300","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635788300?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:06","pubTimestamp":1778666806,"startTime":"0","endTime":"0","summary":"Azitra posted a net loss of $3.9 million for quarter ended March 31, 2026, widening from $3.1 million year earlier.R&D expense rose to $1.6 million from $1.3 million, while G&A costs increased to $2.4 million from $1.9 million.Cash and cash equivalents totaled $10.1 million at quarter-end.Topline data for ATR-12 Phase 1b trial in Netherton syndrome anticipated H2 2026; management cited a strengthened balance sheet and multiple near-term catalysts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 13, 2026, and is solely responsi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL8PtMlt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633138484","title":"Azitra wins new US patent protecting ATR-12 Netherton syndrome program","url":"https://stock-news.laohu8.com/highlight/detail?id=2633138484","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633138484?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:06","pubTimestamp":1778069202,"startTime":"0","endTime":"0","summary":"Azitra won a new U.S. patent covering ATR-12, its lead engineered S. epidermidis program for Netherton syndrome.Patent 12,606,610 B2, titled “Compositions and Methods for Treatment of Netherton Syndrome with LEKTI Expressing Recombinant Microbes,” issued April 21, 2026.Claims cover microbes that secrete one or more LEKTI protein domains, including methods of using them to treat skin diseases such as Netherton syndrome.ATR-12 is in a Phase 1b trial in adults, targeting a rare chronic disease estimated to affect about 20,000 patients globally.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL7yWB28:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633813858","title":"Azitra, Inc. Announces New U.S. Patent Protecting Atr-12 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2633813858","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633813858?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:01","pubTimestamp":1778068919,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J0TQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630301440","title":"Azitra presents preclinical ATR-01 data supporting first-in-human ichthyosis vulgaris trial planning","url":"https://stock-news.laohu8.com/highlight/detail?id=2630301440","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630301440?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:12","pubTimestamp":1777378326,"startTime":"0","endTime":"0","summary":"Azitra announced new preclinical results for ATR-01 in ichthyosis vulgaris will be presented at ASGCT 2026.Data support ATR-01 candidate ATR01-616 delivering functional filaggrin into skin, aiming to address underlying filaggrin deficiency.Studies showed improved skin barrier function, supporting advancement toward IND-enabling work and first-in-human testing.Program uses engineered Staphylococcus epidermidis in a topical formulation to provide localized protein delivery to affected skin.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Azitra Inc. published the original content used to generate this news brief via PR Newswire  on April 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL1RyvvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621706903","title":"Azitra prices private placement for up to USD 31 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621706903","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621706903?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:02","pubTimestamp":1774270936,"startTime":"0","endTime":"0","summary":"Azitra entered into a securities purchase agreement with new and existing institutional investors for gross proceeds of up to USD 31.4 million.The transaction includes initial gross proceeds of about USD 10.5 million, plus up to USD 20.9 million upon potential cash exercise of warrants.Securities sold consist of 10,470 shares of Series A convertible preferred stock and warrants to purchase up to 85,101,201 shares of common stock.The Series A preferred stock was sold at USD 1,000 per share, and the warrants have an exercise price of USD 0.12 per share.The issuance was made under exemptions from registration requirements, and Azitra must register the resale of shares issuable upon conversion and warrant exercise.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, invest","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL62xjZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620736590","title":"Why Is Azitra Inc Stock (AZTR) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620736590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620736590?lang=en_us&edition=fundamental","pubTime":"2026-03-20 20:36","pubTimestamp":1774010165,"startTime":"0","endTime":"0","summary":"Azitra Inc stock climbed on Friday after the company revealed details of a private placement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-azitra-inc-stock-aztr-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-azitra-inc-stock-aztr-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620278576","title":"Azitra Reports Private Placement Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2620278576","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620278576?lang=en_us&edition=fundamental","pubTime":"2026-03-20 01:49","pubTimestamp":1773942548,"startTime":"0","endTime":"0","summary":"Azitra  said Thursday it has struck a deal to sell about $10.5 million in convertible preferred stock to new and existing healthcare-focused institutional investors.The deal also includes funding of up to an additional $20.9 million upon exercise of warrants, the clinical-stage firm said. Investors include Stonepine Capital and Nantahala Capital, it added.Azitra said it plans to use the proceeds for research and development, working capital, and general corporate expenses. It expects to close the transaction March 20.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620278431","title":"Azitra Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2620278431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620278431?lang=en_us&edition=fundamental","pubTime":"2026-03-20 01:45","pubTimestamp":1773942316,"startTime":"0","endTime":"0","summary":"13:45 EDT Azitra (AZTR) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/azitra-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/azitra-inc-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AZTR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.azitrainc.com","stockEarnings":[{"period":"1week","weight":-0.0602},{"period":"1month","weight":-0.4021},{"period":"3month","weight":-0.375},{"period":"6month","weight":-0.5103},{"period":"1year","weight":-0.9156},{"period":"ytd","weight":-0.4637}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1111},{"period":"6month","weight":0.0877},{"period":"1year","weight":0.2063},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.067983},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.19875},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.00274},{"month":4,"riseRate":1,"avgChangeRate":0.06636},{"month":5,"riseRate":0,"avgChangeRate":-0.125233},{"month":6,"riseRate":0,"avgChangeRate":-0.274455},{"month":7,"riseRate":0.25,"avgChangeRate":-0.287359},{"month":8,"riseRate":0,"avgChangeRate":-0.252956},{"month":9,"riseRate":0,"avgChangeRate":-0.250365},{"month":10,"riseRate":0,"avgChangeRate":-0.111618},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.177131},{"month":12,"riseRate":0,"avgChangeRate":-0.200843}],"exchange":"AMEX","name":"Azitra Inc","nameEN":"Azitra Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Azitra Inc(AZTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Azitra Inc(AZTR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Azitra Inc,AZTR,Azitra Inc股票,Azitra Inc股票老虎,Azitra Inc股票老虎国际,Azitra Inc行情,Azitra Inc股票行情,Azitra Inc股价,Azitra Inc股市,Azitra Inc股票价格,Azitra Inc股票交易,Azitra Inc股票购买,Azitra Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Azitra Inc(AZTR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Azitra Inc(AZTR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}